Curis, Inc. has made key promotions within its management team infrastructure. The changes are part of the company’s strategy to better align the management structure for its plan to move away from early stage discovery research to develop later stage preclinical and, ultimately, clinical assets. The first later stage program includes cancer targets that are currently in preclinical testing. Curis expects to select the first lead candidate in early 2007 and file an IND during the second ha...